Invivo’s DynaTRIM system is the first commercially available, fully magnetic resonance imaging (MRI)-compatible interventional device for transrectal interventional MRI of the prostate gland.
Pairing DynaCAD for Prostate with DynaTRIM enables a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy.
For more information: www.invivocorp.com
Sept. 24, 2026 — Leica Biosystems,has added two Paige digital pathology AI-enabled products from Tempus to its Aperio AI ...
September 25, 2026 
Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...
September 23, 2026 
Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...
August 21, 2026 
Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...
August 20, 2026 
Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...
August 10, 2026 
Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...
August 06, 2026 
Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...
August 05, 2026 
July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...
July 10, 2026 
July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...
July 10, 2026 
July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy ...
July 09, 2026 